Intensive care unit management of patients with status epilepticus

Thomas P Bleck*

*Corresponding author for this work

Research output: Contribution to journalArticle

20 Scopus citations

Abstract

The intensive care unit management of status epilepticus focuses on patients who are refractory to initial treatment, who have an underlying condition that require critical care management, or who experience respiratory or cardiovascular complications of their therapies. The available data suggest that failure of a first-line anticonvulsant agent to terminate status should lead to the use of a definitive therapy in general anesthetic doses. Midazolam, propofol, and phenobarbital have been used most frequently; the place of newer agents (e.g., valproate, levetiracetam, or topiramate) remains to be determined.

Original languageEnglish (US)
Pages (from-to)59-60
Number of pages2
JournalEpilepsia
Volume48
Issue numberSUPPL. 8
DOIs
StatePublished - Nov 1 2007

Keywords

  • Levetiracetam
  • Lorazepam
  • Midazolam
  • Propofol
  • Status epilepticus
  • Valproate

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Intensive care unit management of patients with status epilepticus'. Together they form a unique fingerprint.

  • Cite this